Literature DB >> 53479

Letter: Bromocriptine in parkinsonism.

A G Debono, I Donaldson, C D Marsden, J D Parkes.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1975        PMID： 53479

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  5 in total

1.  Bromocriptine and dopamine receptor stimulation.

Authors:  A G Debono; C D Marsden; P Asselman; J D Parkes
Journal:  Br J Clin Pharmacol       Date:  1976-12       Impact factor: 4.335

2.  Effect of hypoglycaemia, TRH and levodopa on plasma growth hormone, prolactin, thyrotropin and cortisol in Parkinson's disease before and during therapy.

Authors:  H P Vogel; R Ketsche
Journal:  J Neurol       Date:  1986-06       Impact factor: 4.849

3.  Plasma bromocriptine levels, clinical and growth hormone responses in Parkinsonism.

Authors:  P Price; A Debono; J D Parkes; C D Marsden; J Rosenthaler
Journal:  Br J Clin Pharmacol       Date:  1978-10       Impact factor: 4.335

4.  Prolactin response as an index of dopaminergic receptor function in Parkinson's disease. Correlation with clinical findings and therapeutic response.

Authors:  A Agnoli; M Baldassarre; S Ruggieri; P Falaschi; R D Urso; A Rocco
Journal:  J Neural Transm       Date:  1981       Impact factor: 3.575

Review 5.  Visual hallucinations in the elderly associated with the use of levodopa.

Authors:  A K Banerjee; P G Falkai; M Savidge
Journal:  Postgrad Med J       Date:  1989-06       Impact factor: 2.401
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.